Study reveals how p53 mutations cause tumors to resist cancer immunotherapy
Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant.
Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant.